Kewajiban jangka dawa perusahaan: Qilian International Holding Group (QLI)

Logo grafis Qilian International Corp (QLI)

Export flows for Qilian International (QLI) are under pressure due to trade disputes between Washington and Beijing, which threaten to restrict access to Western investment. The market perceives the asset as speculative due to its limited global presence. The business relies on the production of licorice extracts, utilizing government licenses to protect its market share. The current figure stands at 0.00, and a detailed price chart of long-term debt is provided below.

QLI qlsyy.net: Kewajiban jangka dawa perusahaan ing interval 04.07.2022 - 17.08.2024
Produk asil prodhuksi Qilian International Holding Group

Asset managers require an objective assessment of credit load to analyze business sustainability. This indicator measures the total volume of liabilities with a maturity of over one year, determining the company's financial leverage. By analyzing the trend of the issuer's long-term liabilities, an investor evaluates the balance between growth and default risk. For Qilian International (QLI), this reflects the costs of maintaining integrated raw material supply chains. Debt optimization ensures the seamless operation of regional pharmaceutical logistics hubs.

Karo sapa Qilian International saingan

Silihan lan utang jangka dawa perusahaan HLN|KVUE - Utang jangka dawa perusahaan|Verona Pharma PLC (VRNA) - Kewajiban jangka dawa perusahaan|MENS: Utang jangka dawa perusahaan|Ligand Corp (LGND) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan AMRX|PRGO: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Alvotech SA (ALVO)|LQDA - Utang jangka dawa|Galapagos Genomics - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka dawa ANIP (ANI Pharmaceuticals Corp)|MannKind Corporation - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan AMPH (amphastar.com)|PCRX: Utang jangka dawa perusahaan|Utang jangka dawa ARS Pharmaceuticals Inc (SPRY)|Utang jangka dawa perusahaan Theravance|AQST: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan scPharmaceuticals Inc. (SCPH)|tectonictx.com (TECX) - Tanggungan jangka dawa|Utang jangka dawa perusahaan TNXP (Tonix Pharmaceuticals Holding Corp.)|Gunggunge utang jangka dawa SXT Pharmaceuticals (SXTC)|EPRX - Utang jangka dawa perusahaan|BHST: Utang jangka dawa perusahaan|EXOZ: Utang jangka dawa perusahaan|ORMP - Gunggunge utang jangka dawa|ENTX (Entera Bio Ltd) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan MindWalk Holdings, Inc.|Utang jangka dawa perusahaan ABVC BioPharma Inc (ABVC)|Cumberland Corp - Tanggungan utang jangka dawa perusahaan|Quantum BioPharma Ltd - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan FGEN|Telomir Pharmaceuticals, Inc. - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Rani Therapeutics RANI|synergychc.com (SNYR) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan RLYB|Kewajiban jangka dawa perusahaan LEXX|PULM (pulmatrix.com) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan PTHL|APM - Utang jangka dawa|Utang jangka dawa perusahaan Lyra Therapeutics, Inc LYRA|Silihan lan utang jangka dawa perusahaan IBO|TNFA - Utang jangka dawa perusahaan|YCBD (cbdMD, Inc.) - Tanggungan utang jangka dawa perusahaan|PRFX: Utang jangka dawa perusahaan|Altamira Therapeutics Ltd. (CYTO) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan LIPO|OPTN (OptiNose Corp) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan PIRS|Gunggunge utang jangka dawa procapsgroup.com|Utang jangka dawa perusahaan Petros Pharmaceuticals, Inc. PTPI|Acelyrin Inc. (SLRN) - Utang jangka dawa|TFFP - Utang jangka dawa perusahaan